← Back to all earnings calls

Enanta Pharmaceuticals Inc Q4 FY2020 Earnings Call

Enanta Pharmaceuticals Inc (ENTA)

Earnings Call FY2020 Q4 Call date: 2020-11-23 Concluded

Share

Quarter scorecard

Revenue

$23.63M

-53.9% YoY

Diluted EPS

$-1.46

-431.8% YoY

Net income

-$29.34M

-419.2% YoY

Documents & deck